ImmunoCellular seeks next level leader after CEO resignation 'mess'
This article was originally published in Scrip
Executive Summary
ImmunoCellular Therapeutics founder, chief scientific officer and chairman John Yu told Scrip that the Los Angeles-based cancer vaccine developer is "looking for a leader to take the company to the next level" since president and CEO Manish Singh resigned "to pursue other opportunities."